MedTrace Logo

Psychotherapeutic Imagery Techniques

NCT07048756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2025-08-20

No results posted yet for this study

Summary

This randomized controlled trial (RCT) examines the efficacy of Imagery Exposure (IE), Imagery Rescripting (ImRs), and Compassion-Focused Therapy (CFT) in individuals with a high fear of failure. Participants (N=220) were randomly assigned to IE, ImRs, ImRs with a 10-minute break (ImRs-DSR), or CFT-based Imagery Rescripting (CFT\_ImRs). Due to funding constraints, the CFT\_ImRs group included a reduced sample (N=40, targeting 30 completers).

The two-week intervention consists of four structured imagery sessions. IE involves exposure to criticism-related memories without modification. In the ImRs group memory reactivation to criticism-related memories is followed by positive reappraisal. ImRs-DSR introduces a 10-minute delay before reappraisal to enhance memory updating. CFT\_ImRs incorporates Compassion-Focused Therapy (CFT) principles into reappraisal, emphasizing self-compassion.

Primary outcomes include skin conductance level (SCL) and subjective emotional responses to criticism-related (and control) memories, changes in fear of failure and dysfunctional beliefs. All these variables are assessed pre-treatment, post-treatment, and at 3- and 6-month follow-ups. Results will be analyzed separately for:

IE vs. ImRs (rescripting vs. exposure and physiological predictors), ImRs vs. ImRs-DSR (memory reconsolidation effects), IE vs. CFT\_ImRs (CFT vs. exposure efficacy).

Conditions

  • Fear of Failure

Interventions

BEHAVIORAL

Imagery Rescripting

Imagery Rescripting (Regular)

BEHAVIORAL

Imagery Exposure

Imagery Exposure

BEHAVIORAL

Imagery Rescripting with Disruption of Reconsolidation

Imagery Rescripting with Disruption of Reconsolidation

BEHAVIORAL

Compassion-Focused Therapy Imagery Rescripting

Imagery Rescripting in Compassion-Focused Therapy

Sponsors & Collaborators

  • National Science Centre, Poland

    collaborator OTHER_GOV

  • University of Social Sciences and Humanities, Warsaw

    lead OTHER

Principal Investigators

  • Jarosław M. Michałowski, PhD · SWPS University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2022-06-01
Completion
2022-06-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07048756 on ClinicalTrials.gov